您的位置: 首页 > 农业专利 > 详情页

Novel dosing regimens of celgosivir for the treatment of dengue
专利权人:
Singapore Health Services Pte Ltd;60 Degrees Pharmaceuticals LLC;National University of Singapore
发明人:
Vasudevan, Subhash,Sung, Cynthia,Rathore, Abhay,Watanabe, Satoru,Low, Jenny,Ooi, Eng Eong,Dow, Geoffrey S.,Morrish, Glynn,Reid, Mark
申请号:
AU2014228035
公开号:
AU2014228035B2
申请日:
2014.03.14
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Methods of treating a dengue virus (DENV) infection in a human subject, comprising administering to the human subject a compound of Formula (I), or pharmaceutical composition comprising a compound of Formula (I):A compound of Formula (I) can be administered within onset of fever to 72 hours of fever onset due to dengue infection and then every 6 to12 hours until there is an improvement in the infection or between from about 1 day to about 10 days. The methods of the invention can be used to treat primary and secondary DENV1-4 viral infections.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充